Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
Tiziana Triulzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Elda Tagliabue(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 96
Related Papers
Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
|Seminars in Cancer Biology|2015|153
<scp>SAA1</scp>‐dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness
|International Journal of Cancer|2024|16
Impact of in vitro SARS-CoV-2 infection on breast cancer cells
|Scientific Reports|2024|2